Plain-English translation of NCT06781879 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial compares two approaches to treating bladder cancer that has come back after previous treatment. One group receives a newer approach using (a chemotherapy medication applied directly into the bladder) followed by additional treatment if needed. The other group receives the standard approach of surgical removal of tumors followed by chemotherapy instilled into the bladder. The goal is to see which approach works better over the long term.
Bladder cancer that comes back repeatedly is very common and expensive to treat because patients need frequent procedures and follow-up visits. Researchers want to know if this newer medication-based approach might prevent tumors from returning better than the current standard treatment, which could reduce the number of future procedures patients need.
You likely qualify if…
You likely don't qualify if…
If assigned to the new approach, you would receive the medication instilled directly into your bladder three times per week for two weeks, then have an imaging procedure eight weeks later to check your response. Depending on results, you may receive additional monthly treatments or proceed to standard surgery and immunotherapy. If assigned to the standard approach, you would have surgery to remove tumors followed by chemotherapy instilled into your bladder. Both groups involve regular follow-up visits according to standard medical guidelines.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
Denmark
Iceland